Keymed Biosciences, Inc.

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5252B1023
HKD
54.55
-1.3 (-2.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Keymed Biosciences, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-545.00
-388.00
-341.00
-4,690.00
-920.00
-189.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-139.00
24.00
-6.00
3.00
0.00
-7.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-592.00
-254.00
-409.00
-251.00
-128.00
-76.00
Cash Flow from Investing Activities
-3.00
257.00
-811.00
-2,460.00
-115.00
46.00
Cash Flow from Financing Activities
327.00
257.00
-7.00
4,385.00
-8.00
459.00
Net Cash Inflow / Outflow
-262.00
272.00
-1,065.00
1,592.00
-262.00
435.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
5.00
11.00
161.00
-80.00
-9.00
5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Keymed Biosciences, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-545.788524302128
3566.10979815721
-4,111.00
-115.30%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-139.65019936225
124.403843689458
-263.00
-212.26%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-592.75818538326
3533.15481446415
-4,125.00
-116.78%
Cash Flow from Investing Activities
-3.58769669484703
-1905.81072252745
1,902.00
99.81%
Cash Flow from Financing Activities
327.482222061554
682.308569433831
-355.00
-52.00%
Net Cash Inflow / Outflow
-262.99584058092
2309.36317360459
-2,571.00
-111.39%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
5.86781943563376
-0.289487765949844
5.00
2126.97%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -133.34% vs 37.90% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-592.76
-254.03
-133.34%